Cargando…
Epidrugs: novel epigenetic regulators that open a new window for targeting osteoblast differentiation
Efficient osteogenic differentiation of mesenchymal stem cells (MSCs) is a critical step in the treatment of bone defects and skeletal disorders, which present challenges for cell-based therapy and regenerative medicine. Thus, it is necessary to understand the regulatory agents involved in osteogene...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7594482/ https://www.ncbi.nlm.nih.gov/pubmed/33115508 http://dx.doi.org/10.1186/s13287-020-01966-3 |